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Background: Valve effective orifice area EOA and transvalvular mean pressure gradient (MPG) are the most
frequently used parameters to assess aortic stenosis (AS) severity. However, MPG measured by cardiovascular
magnetic resonance (CMR) may differ from the one measured by transthoracic Doppler-echocardiography (TTE).
The objectives of this study were: 1) to identify the factors responsible for the MPG measurement discrepancies by
CMR versus TTE in AS patients; 2) to investigate the effect of flow vorticity on AS severity assessment by CMR; and
3) to evaluate two models reconciling MPG discrepancies between CMR/TTE measurements.
Methods: Eight healthy subjects and 60 patients with AS underwent TTE and CMR. Strouhal number (St), energy
loss (EL), and vorticity were computed from CMR. Two correction models were evaluated: 1) based on the Gorlin
equation (MPGCMR-Gorlin); 2) based on a multivariate regression model (MPGCMR-Predicted).
Results: MPGCMR underestimated MPGTTE (bias = −6.5 mmHg, limits of agreement from −18.3 to 5.2 mmHg). On
multivariate regression analysis, St (p = 0.002), EL (p = 0.001), and mean systolic vorticity (p < 0.001) were
independently associated with larger MPG discrepancies between CMR and TTE. MPGCMR-Gorlin and MPGTTE
correlation and agreement were r = 0.7; bias = −2.8 mmHg, limits of agreement from −18.4 to 12.9 mmHg.
MPGCMR-Predicted model showed better correlation and agreement with MPGTTE (r = 0.82; bias = 0.5 mmHg, limits of
agreement from −9.1 to 10.2 mmHg) than measured MPGCMR and MPGCMR-Gorlin.
Conclusion: Flow vorticity is one of the main factors responsible for MPG discrepancies between CMR and TTE.
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Flow vorticityBackground
Valve effective orifice area (EOA) and mean transvalvular
pressure gradient (MPG) are the most frequently used pa-
rameters to assess aortic stenosis (AS) severity [1]. Current
ACC/AHA and ESC guidelines suggest an EOA < 1.0 cm2
and a MPG > 40 mmHg as main criteria to define a severe
AS [1,2]. Transthoracic Doppler-echocardiography (TTE)
is the primary method utilized in clinical practice to assess* Correspondence: Philippe.Pibarot@med.ulaval.ca; Eric.Larose@criucpq.ulaval.ca
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reproduction in any medium, provided the orand grade AS severity. Since TTE has some theoretical and
technical limitations [1] cardiovascular magnetic resonance
(CMR) has emerged as a non-invasive, radiation-free ac-
curate alternative method to corroborate AS severity when
uncertain or discordant results are obtained at TTE [3-6].
However, previous studies have showed that MPG mea-
sured by CMR may differ from the one obtained by TTE,
mainly when transvalvular velocity is greater than 4 m/s
[3,4,7-10]. It was hypothesized that this underestimation
might be due to the following factors: flow turbulence gen-
erated downstream the severe AS, local signal loss, back-
ground noise and phase wrap [7,11-14].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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AS severity assessed by TTE and cardiac catheterization
[15] it has been proposed to use Gorlin equation to
correct the MPG disagreement between TTE and CMR
measurements [16] leading to reasonable results in the
evaluated population. From a fluid dynamic point-of-view,
when the blood flows through the aortic valve it is
spatially accelerated from the left ventricular outflow tract
(LVOT) to the location of the vena contracta and it is then
decelerated and diverges within the ascending aorta
(Figure 1). This flow generates turbulence when the aortic
valve is severely stenotic and an irreversible heat dissipa-
tion process. Several flow-derived parameters (energy loss,
vorticity, and Strouhal number) may provide an insight on
the presence and intensity of turbulence generated down-
stream of a severe AS [17]. All these flow parameters may
be useful for identifying potential sources of discordance
between MPG measured by CMR and TTE.
Energy loss (EL) represents the energetic cost (in mmHg)
between the LVOT and the ascending aorta after pressureFigure 1 Fluid mechanics of the aortic valve. Schematic representation
aorta with corresponding static pressure (P) and energy in terms of total p
V indicates LVOT velocity, AOA indicates anatomic aortic area and VC indic
corresponds to the valve effective orifice area. Magnetic resonance velocity
were used to compute dimensionless flow parameters and vorticity magnirecovery [18-22]. Vorticity intensity (ω) can be used to esti-
mate the dissipation effects within the flow [23]. Interest-
ingly, a recent study demonstrated that vorticity jet shear
layer can also be used to estimate EOA using CMR velocity
measurements [5]. Strouhal number (St) represents the di-
mensionless oscillating flow through the aortic valve [24].
The objectives of this study were: 1- to identify the fac-
tors responsible for the discrepancies in the MPG meas-
urement by CMR versus TTE in patients with AS, 2- to
investigate the effect of vorticity on AS severity assessment
by CMR and 3- to evaluate two models to reconciling
MPG discrepancies between CMR/TTE measurements.
Methods
Study population
Eight (8) healthy control subjects and 60 patients with
mild to severe AS (0.60 cm2 ≤ EOATTE ≤ 1.79 cm
2)
underwent comprehensive research TTE and CMR
exams in the context of this study. All subjects were
prospectively recruited based on standard clinical TTEof the system composed of left ventricle, aortic valve and ascending
ressure (P+4 V2). LVOT indicates left ventricular outflow tract,
ates the vena contracta position, cross-sectional area of VC
measurements at vena contracta (10 mm from the aortic valve)
tude. AAo indicates ascending aorta.
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cluded. Exclusion criteria were: age < 21 years old, LV
ejection fraction < 50%, more than mild mitral disease
or aortic regurgitation, poor TTE imaging quality and
standard contra-indications to magnetic resonance im-
aging. The study was approved by the Ethical Review
Board (Comité d’Éthique de la Recherche, Institut
Universitaire de Cardiologie et de Pneumologie de Québec)
and all patients provided written informed consent for
their participation in this study.
Transthoracic Doppler-echocardiography
TTE studies were performed and analyzed by two experi-
enced echocardiographers according to the American So-
ciety of Echocardiography guidelines [25] and included:
1) Valve hemodynamics: transvalvular pressure gradients
were determined by simplified Bernoulli formula:
MPGTTE = 4 × Vmean
2 , where V is the mean systolic
aortic transvalvular velocity; and valve EOA was
calculated by continuity equation: EOATTE = SVLVOT/
VTIAo = (VTILVOT × ALVOT) / VTIAo, where SVLVOT
is the stroke volume measured in the LVOT, ALVOT is
the cross-sectional area of the LVOT and VTILVOT and
VTIAo are the velocity-time integrals at the LVOT
and the vena contracta, respectively. AS severity
was classified on the basis of TTE-derived EOA:
Mild to moderate (EOA> 1.0 cm2) and severe (EOA
≤ 1.0 cm2);
2) Parameters of arterial hemodynamics: Systemic arterial
compliance (SAC) was computed using the following
formula: SAC = SVi/PP, where SVi is the stroke
volume indexed to the body surface area and PP is
the pulse arterial pressure. Systemic vascular resis-
tance (SVR) was also estimated from the following
formula: SVR = 80MAP/80 × MAP /CO, where
MAP is the mean arterial pressure and CO is the
cardiac output.
Cardiovascular magnetic resonance
CMR studies were performed 2 to 4 weeks after TTE
with patients in comparable hemodynamic state (SVTTE =
80±14 vs. SVCMR = 77±17, p=NS; heart rate TTE =
63±10 bpm vs. heart rate CMR = 65±11 bpm, p = NS).
Imaging was performed with a 1.5 Tesla Philips Achieva
scanner operating release 2.6 level 3 and dedicated
phased-array cardiac coil during successive end-expiratory
breath-holds (Philips Healthcare, Best, The Netherlands)
as described in previous studies [3,5,6]. Typical parameters
included TR/TE of 3.4/1.2 ms, flip angle 40°, NEX of
1, yielding in-plane spatial resolution of 1.6×2 mm.
Through-plane phase-contrast imaging was performed
during breath-hold in the LVOT at 12 mm upstream
from the aortic valve annulus (reference: 0 mm), in theascending aorta (Ao) at 10 mm downstream of the aortic
annulus, both planes parallel to the aortic valve annulus
plane. Flow imaging parameters consisted of: TR/TE =
4.60-4.92/2.76-3.05 ms, flip angle = 15°, 24 phases, pixel
spacing = 1.32–2.07 mm, slice thickness = 10 mm and ac-
quisition matrix = 256 × 208, scan time = 10–25 s without
SENSE. For each patient, peak aortic jet velocity measured
by TTE was used to define CMR encoding velocity (CMR
encoding velocity = (1.25 to 1.5) × peak jet velocity, range
from 1.5 to 5.5 m/s) to optimally define resolution and
avoid signal wrap.
CMR images acquisitions and analyses were performed
by investigators blinded to clinical and TTE results. A
custom-made research application was developed using
Matlab software (Mathworks, Natick, Ma, USA) to
process and analyze velocity-encoded images [5,26] and
the image stack was processed to filter background
noise. Regions of interest (ROIs) were defined on each
of the 24 phases of anatomical magnitude images to in-
clude the lumen of the LVOT and of the aorta. The fol-
lowing measurements were performed within each ROI
on matched phase images at LVOT and Ao positions.
The peak and average flow velocities within the ROI
were used to determine the changes in instantaneous
peak and average velocity (Vaverage) in the LVOT during
the cardiac cycle. The instantaneous LVOT flow rate was
calculated by multiplying the instantaneous Vaverage by
the LVOT cross-sectional area.
The maximum through-plane flow velocity within the
ROI was used to determine the instantaneous peak aor-
tic velocity at Ao position. The mean transvalvular vel-
ocity was computed using instantaneous peak velocity
values during systole (i.e. ejection period).CMR valve hemodynamic parameters
Mean transvalvular pressure gradient (MGPCMR) was de-
termined by simplified Bernoulli formula and valve EOA
was calculated using jet shear layer detection method [5]
from velocity field at Ao plane (i.e. 10 mm downstream
of the aortic annulus). The same plane was used to com-
pute energy loss (EL = Vpeak
2 × [1 − EOACMR/AAo]
2),
where Vpeak
2 is the systolic transvalvular aortic peak
jet velocity and AAo is cross-sectional area of the as-
cending aorta. Systolic mean vorticity (ω t½  ¼ ∂V t½ ∂x − ∂V t½ ∂y )
was computed using a compact-Richardson interpolation
scheme [27-29], absolute value was used to consider
both clockwise and anti-clockwise effects. Briefly, compact-
Richardson interpolation scheme estimates the partial
velocity derivatives needed for the vorticity computation
with reduced partial volume effects and local noise alter-
ations using an iterative-weighted process. This vorticity
method works with through-plane (single velocity compo-
nent) and full volume (three velocity components, i.e. full
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in silico, in vitro and in vivo [27-29]. Furthermore Strouhal
number (non-dimensional oscillating flow) was given by
St = (Daverage//2) × (f/[/ [Vpeak − Vaverage]), where Daverage
is the averaged systolic diameter of LVOT and f is the
heart rate.
To assess the discordance between MPG obtained by
CMR and MPG obtained by TTE, the MPG relative error
(in %) was computed as follows: MPGerror = ([MPGTTE −
MPGCMR]/] /MPGTTE) × 100. Absolute error differences
(|ΔMPG|) were classified in three groups: group A
(|ΔMPG| ≤ 10 mmHg), group B (10 mmHg < |ΔMPG|
< 20 mmHg) and group C (|ΔMPG| ≥ 20 mmHg). Pre-
dicted MPGCMR-Gorlin was computed using Gorlin
equation as follows: MPGCMR − Gorlin = (CO/[/ [HR ×
SEP × 44.3 × EOACMR])
2 [15,16,30], where CO is the
cardiac output, HR is the heart rate and SEP is the systolic
ejection period.Statistical analyses
Results are expressed as mean ± SD. Comparisons be-
tween groups (healthy control subjects vs. moderate vs. se-
vere AS or tricuspid vs. bicuspid valve) were performed
with the use of Student t-tests or One-way ANOVA when
appropriate. Association and agreement between variables
were assessed by Pearson’s correlations and Bland-Altman
methods, respectively. Multivariate linear regression ana-
lysis was performed to identify the factors independently
associated with MPGerror and MPGTTE. We included in
multivariate models age and AS severity defined by CMR
(i.e. EOACMR or MPGCMR) and all variables with p-
value<0.15 in univariate analysis. Standardized regression
coefficients were presented as mean ± standard error (βeta
coeff ± SE). Statistical analysis was performed with SPSS
17 (SPSS, Chicago, IL).Results
Sixty patients with mild to severe AS (65% men, age
64±15 years) and eight healthy subjects (75% men, age
34±8 years) were included in this study. The demo-
graphic, TTE and CMR data of the patients with AS and
the healthy subjects are presented in Table 1. Valve
morphology was bicuspid in 27% of AS patients. Age,
MPG, EL, vorticity, and Strouhal number were signifi-
cantly higher in AS patients compared with healthy
control subjects. When comparing AS severity groups
with healthy control subjects a significant difference
was found for AS severity indices, EL, vorticity, and
Strouhal number. There was a significant difference
(p<0.05) between aortic valve phenotype (i.e. bicuspid
vs. tricuspid aortic valves) for age, systolic arterial pres-
sure, and systemic compliance.Factors of the MPG underestimation by CMR
MPGCMR underestimated MPGTTE and this underesti-
mation increased with AS severity (r = 0.73 [Figure 2A];
bias = −6.5 mmHg, limits of agreement from −18.3 to
5.2 mmHg, [Figure 2B], Table 1). Comparison between
MPGCMR and MPGTTE was significantly different for
all categories (p<0.001). When considering |ΔMPG|
groups, group A had 78% (n = 53) of subjects, group B
had 21% (n = 14) of subjects and group Chad 1% (n = 1)
of subjects. Vorticity (p = 0.003), EL (p = 0.006) and
Strouhal number (p = 0.123) were significantly related
to MPGerror (Table 2). In the multivariate analysis, after
adjustment for EOACMR and age, EL, Strouhal number
and vorticity were the factors independently associated
with higher MPGerror (Table 2).
TTE and CMR transvalvular mean pressure gradient
prediction models
MPGCMR-Gorlin and MPGTTE measurements showed a
good correlation and agreement, a reduced underestima-
tion with higher limits of agreement than measured
MPGCMR (r = 0.7 [Figure 2C]; bias = −2.8 mmHg, limits of
agreement from −18.4 to 12.9 mmHg, [Figure 2D]). When
considering |ΔMPG| groups, group A had 76% (n = 52) of
subjects, group B had 21% (n = 14) of subjects and group
C had 3% (n = 2) of subjects.
Independent factors associated to MPGerror were in-
cluded, avoiding redundancies, in a multivariate analysis
for MPGTTE adjusted to MPGCMR; all the parameters in-
cluded were significantly associated in the univariate
analysis (p < 0.001, see Table 3).
In this multivariate analysis MPGCMR, Strouhal num-
ber and mean vorticity were independently associated to
MPGTTE. We have introduced a new MPGCMR-Predicted
model based in the previous multivariate analysis
presented in Table 3:
MPGCMR−Predicted ¼ 24−0:05mean ωþ 0:85
MPGCMR−960 St
Where ω is the vorticity magnitude and St is the
Strouhal number. MPGCMR-Predicted model showed better
correlation with MPGTTE and a low overestimation with
lower limits of agreement (r = 0.82 [Figure 2E]; bias =
0.5 mmHg, limits of agreement from −9.1 to 10.2
mmHg, [Figure 2F]) than measured MPGCMR and
MPGCMR-Gorlin. When considering |ΔMPG| groups,
group A had 99% (n = 67) of subjects and group B had
1% (n = 1) of subjects.
Discussion
The main findings of this study are: 1) Mean systolic
vorticity and EL were the factors associated with the dis-
crepancies between CMR and TTE for the measurement
Table 1 Comparison of clinical TTE and CMR data
Healthy subjects AS patients
(n=8, mean±SD) (n=60, mean±SD)
Patient demographics
Age (years) 34 ± 8 64 ± 15 *
Gender (men %) 75 65
Body surface area (m2) 1.93 ± 0.26 1.82 ± 0.19
Systolic arterial pressure (mmHg) 116 ± 10 132 ± 23
Diastolic arterial pressure (mmHg) 77 ± 5 72 ± 12
Doppler echocardiography data
Valve phenotype (bicuspid, %) 36
Aortic valve hemodynamics
Stroke volume (mL) 80 ± 20 80 ± 13
Mean transvalvular gradient (mmHg) 5 ± 1 20 ± 10 *
Valve effective orifice area (cm2) 2.67 ± 0.47 1.19 ± 0.28 *
Systemic arterial hemodynamics
Systemic arterial compliance (mL.m-2.mmHg-1) 1.06 ± 0.21 0.91 ± 0.32
Systemic vascular resistance (dyne.s.cm-5) 1448 ± 319 1515 ± 338
Cardiovascular magnetic resonance data
Aortic valve hemodynamics
Stroke volume (mL) 84 ± 14 76 ± 17
Mean transvalvular gradient (mmHg) 3 ± 1 12 ± 7 *
Valve effective orifice area (cm2) 3.08 ± 0.8 1.4 ± 0.41 *
Energy loss (mmHg) 3.33 ± 1.11 13.81 ± 7.99 *
Mean systolic vorticity (1/s) 88 ± 13 125 ± 35 *
Strouhal 0.0174 ± 0.0034 0.0087 ± 0.0029 *
*:p<0.001 with healthy.
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parameter of AS hemodynamic severity; 3) The intro-
duction of a new MPGCMR-Predicted model based on
mean vorticity and oscillating flow(Strouhal number)
allowing a better correlation and agreement than
MPGCMR-Gorlin.
MPGTTE underestimation by CMR is typically related to
local signal loss, background noise, phase wrap and turbu-
lence [7,9-14,31,32]. However, as it was demonstrated with
catheterization other hemodynamic parameters affect
mean transvalvular pressure gradients measurements,
mainly energy loss [21] and pressure recovery [18-22,33].
Those explanations should also apply to CMR given the
theoretical background of the measurements. Some previ-
ous studies used those similarities to estimate EOA with
CMR [9,10]. Reynolds number (ratio of the inertial/viscous
forces) has been shown to be a dimensionless parameter
contributing to the explanation of pressure gradient differ-
ences between TTE and catheterization in AS [34,35].
However, it is mainly valid in steady flow conditions evalu-
ating flow regimes (laminar or turbulent).In this study, a predictive MPG model using Gorlin
equation [15,16,30] and CMR measurements was used.
MPGCMR-Gorlin reduced CMR-TTE bias differences but it
showed important differences with AS severity increase
(i.e. higher MPG) (Figure 2, panel C and D). It is import-
ant to notice that we used the Gorlin equation based on
Minners et al. study [15] and preliminary reported re-
sults [16]. However, it was been demonstrated that
Gorlin equation have two small errors: 1) the use of
mean flow instead of root-mean-square flow and 2) the
use of the coefficient 44.3 instead of 50.5 [36]. The ori-
ginal intent of Gorlin equation was to give an estimate
of anatomic valve area (AVA) instead of EOA. Of inter-
est, EOA represent better the aortic valve hemodynamic
than AVA and similar AVA geometries could lead to dif-
ferent EOA, i.e. different AS severities [37].
A new predictive model based on vorticity and dimen-
sionless oscillating flow (Strouhal number) was evaluated
and led to a better MPG estimation from CMR (Figure 2,
panel C and D). The new MPGCMR-Predited model intro-
duced in this study showed that MPG can be accurately
Table 2 Univariate and multivariate determinants of relative error in transvalvular mean pressure gradient
Mean transvalvular pressure gradient Univariate analysis Multivariate model
Relative error = MRI-TTE/TTE (%) βeta coeff ± SE p-value βeta coeff ± SE p-value
Age (years) 0.19 ± 0.19 0.123 - 0.609
Effective orifice area (cm2)* −0.14 ± 4.66 0.256 - 0.112
Strouhal number* −0.19 ± 809 0.123 −0.46 ± 934 0.002
Energy loss (mmHg)* −0.33 ± 0.37 0.006 −0.41 ± 0.36 0.001
Mean systolic vorticity (1/s)* −0.36 ± 0.09 0.003 −0.53 ± 0.08 <0.001
Legend: *Parameters computed from CMR. Multivariate model includes only variables that were significantly (p<0.15) associated with transvalvular mean pressure
gradient relative error on univariate analysis. Βeta coeff ± SE were standardized regression coefficients ± standard error.
Figure 2 Comparison of mean transvalvular pressure gradients measured by TTE versus by CMR. Panel A shows the Pearson correlation
plot for mean transvalvular pressure gradient measured by TTE (MPGTTE) and CMR (MPGCMR). Panel B shows the corresponding Bland-Altman plot.
Panel C shows the Pearson correlation plot for mean transvalvular pressure gradient measured by TTE (MPGTTE) and predicted by Gorlin equation
using CMR (MPGCMR-Gorlin). Panel D shows the corresponding Bland-Altman plot. Panel E shows the Pearson correlation plot for mean
transvalvular pressure gradient measured by TTE (MPGTTE) and predicted model using vorticity and dimensionless stroke volume from CMR
(MPGCMR-Predicted). Panel F shows the corresponding Bland-Altman plot.
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Table 3 Univariate and multivariate determinants of Doppler-echocardiography mean transvalvular pressure gradient
Doppler-Echocardiography mean
transvalvular mean pressure gradient
(mmHg)
Univariate analysis Multivariate model
βeta coeff ± SE p-value βeta coeff ± SE p-value
Mean transvalvular pressure gradient (mmHg)* 0.73 ± 0.1 <0.001 0.72 ± 0.19 <0.001
Energy loss (mmHg)* 0.68 ± 0.09 <0.001 - 0.98
Strouhal number* −0.57 ± 224 <0.001 −0.44 ± 202 <0.001
Mean systolic vorticity* 0.48 ± 0.03 <0.001 −0.21 ± 0.03 0.07
Legend: *Parameters measured by CMR. Multivariate model includes only variables that were significantly (p < 0.001) associated with echo-Doppler transvalvular
mean pressure gradient on univariate analysis. Βeta coeff ± SE were standardized regression coefficients ± standard error.
Figure 3 Effective orifice area and mean transvalvular pressure
gradients. Panel A shows the aortic valve effective orifice area
and mean transvalvular pressure gradient (MPG) plot using
measurements from TTE (MPGTTE) and CMR (MPGCMR). Panel B
shows the same plot but using MPG predicted by Gorlin equation
and CMR measurements (MPGCMR-Gorlin). Panel C shows the same
plot but using MPG predicted using mean vorticity magnitude
and dimensionless stroke volume from CMR measurements
(MPGCMR-Predicted).
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CMR as corroboration imaging technique for AS sever-
ity [3,4,8]. It may be also useful in the management of
inconsistent severity grading (Figure 3), a current sce-
nario between TTE and cardiac catheterization [15], and
as it is demonstrated in this study (Table 2, Figure 3A),
between TTE and CMR. Inconsistencies on EOA and
MPG measurements may lead to incorrect therapeutic/
surgical decisions. It is important to avoid measurement
inconsistencies as reported with cardiac catheterization
and define consistent cut-offs (EOA and pressure gradi-
ents) valid on all imaging techniques used to assess AS
severity.
Furthermore, energy loss was evaluated using CMR
and was strongly associated to MPGerror, mean vorticity
intensity and dimensionless oscillating flow. A recent
substudy of SEAS cohort [22] showed the potential use-
fulness of energy loss, pressure recovery and energy loss
coefficient ([EOA×AAo] / [AAo-EOA]) for AS severity as-
sessment, highlighting the importance of this parameter
unexplored in CMR. A more accurate evaluation of en-
ergy loss and vorticity may be computed using CMR 4D
flow velocity measurements [29,38-40].
The cohort and results presented in this study make part
of an ongoing prospective study at our institution. Some
of our previous works included a part or the integrity of
the actual cohort exploring different topics. Briefly, our
work comparing continuity equation EOA using TTE and
CMR used 48% of the actual data [3], the introduction a
novel EOA method with CMR used 57% [5], two closely
related works exploring pressure gradient difference be-
tween TTE and CMR used 48% [16], and the same cohort
[17]. Finally, the cohort presented in this work was in-
cluded in a more recent study evaluating the valve EOA
kinetic in patients with AS [6]. Patients with bicuspid valve
showed a ratio close to 30% of the ongoing population.
In terms of methodology it is important to observe
that the initial imaging work flow included measure-
ments at 6 mm and 10 mm downstream from the aortic
valve. Measurements at 6 mm showed to be slightly
higher than those at 10 mm [3]. However, 6 mm plane is
unusual in clinical practice [4] and it was found none
statistical difference between both velocity planes. So
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plane position to the aortic valve annulus may crucial
for the adequate measurement of velocity gradients at
vena contracta position, avoiding potential sources of
velocity underestimation [4,5,8]. In particular the pres-
ence of high eccentric flow jets, often observed in pa-
tients with bicuspid aortic valves and aortic dilation,
may contribute to pressure gradient underestimation
[41,42]. However, AS severity does not seem to be the
only factor affecting flow jet eccentricity, complex rota-
tory flow patterns and velocity-related measurements
[42,43]. In this study non-statistical difference was found
when comparing bicuspid vs. tricuspid MPG.
Vortex formation is currently visually evaluated for
identifying abnormal flow patterns [41,42,44,45]. How-
ever vorticity intensity provides a quantitative approach
of vorticity and vortex formation. In this study MPG,
EOA, energy loss, and Strouhal number (dimensionless
oscillating flow) were significantly associated with mean
vorticity. Vorticity was also used to compute EOA using
vorticity jet shear layer detection method [5,17,29], this
method may be more accurate than continuity equation
and may be useful for differentiating pseudo-severe AS
to truly-severe AS severity at rest or during dobutamine
perfusion [23] given its high-accurate fluid mechanics
approach, non-circular LVOT shape assumptions and/or
stroke volume computation need. Vorticity intensity
may provide useful additional information of aortic valve
hemodynamics and AS severity.
Study limitations
Accurate estimation of valve vorticity magnitude is
dependent on the temporal and spatial resolution (typic-
ally 30–40 ms per phase and 1–2 mm, respectively) which
is essentially determined by patient’s heart rate, sequence
design and echo time. In this study we use a vendor prod-
uct flow sequence which automatically estimates the
shorter TE, however TE was maybe not enough shorter to
accurately measure peak velocities [14]. New promising
fast acquisition flow sequences and hardware (i.e. SENSE,
image mapping, ultra-short echo time, and parallel im-
aging) could help overcoming these limitations. It is im-
portant to notice that vorticity was calculated using
standard through-plane velocity measurements (i.e. a sin-
gle velocity component). As presented in the discussion
full velocity vector acquisition may provide a more accur-
ate estimation of vorticity. The number of patients with
AS and adverse events was too small (7 valve replacement
surgeries) to determine the association between valve vor-
ticity intensity with clinical outcomes.
Conclusion
In conclusion, this study showed that flow vorticity is one
of the main factors responsible for the MPG discrepanciesbetween CMR and TTE. It is possible to account for this
factor and correct the MPG measured by CMR. Larger
studies are needed to confirm the potential usefulness of
CMR-derived vorticity and flow-derived parameters in
cardiovascular diseases and valve function.
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